Diagnosis and Time to Treatment for Pediatric Patients with Gender Dysphoria

Saved in:
Bibliographic Details
Title: Diagnosis and Time to Treatment for Pediatric Patients with Gender Dysphoria
Language: English
Authors: Ted Handler, Maqdooda Merchant, Claudia Guzik, Shelby Chen, Nathan Kralik, Anthonia Ojo, Eve Zaritsky
Source: Journal of LGBT Youth. 2024 21(1):20-28.
Availability: Routledge. Available from: Taylor & Francis, Ltd. 530 Walnut Street Suite 850, Philadelphia, PA 19106. Tel: 800-354-1420; Tel: 215-625-8900; Fax: 215-207-0050; Web site: http://www.tandf.co.uk/journals
Peer Reviewed: Y
Page Count: 9
Publication Date: 2024
Document Type: Journal Articles
Reports - Research
Descriptors: Children, Sexual Identity, Gender Differences, Intervention, LGBTQ People, Access to Health Care, Health Needs, Adolescents, Clinical Diagnosis
Geographic Terms: California
DOI: 10.1080/19361653.2022.2139788
ISSN: 1936-1653
1936-1661
Abstract: A cohort of pediatric patients with gender dysphoria was studied to determine differences in gender-affirming care by patient characteristics. This study found that patients were diagnosed, on average, between 13 and 15 years of age. Patients who were assigned male sex at birth were more likely to be diagnosed at a younger age and receive puberty blockers as their first treatment, while those assigned female sex at birth were more likely to be diagnosed at an older age and start gender-affirming hormone therapy first. Patients who identified as female were more likely to receive any gender-affirming treatment than male-identifying or nonbinary patients. These findings characterize some of the many factors that impact the timing and type of care gender diverse patients receive. These data further our understanding of the pediatric gender diverse population and of their medical gender-affirming care needs.
Abstractor: As Provided
Entry Date: 2024
Accession Number: EJ1409121
Database: ERIC
Description
Abstract:A cohort of pediatric patients with gender dysphoria was studied to determine differences in gender-affirming care by patient characteristics. This study found that patients were diagnosed, on average, between 13 and 15 years of age. Patients who were assigned male sex at birth were more likely to be diagnosed at a younger age and receive puberty blockers as their first treatment, while those assigned female sex at birth were more likely to be diagnosed at an older age and start gender-affirming hormone therapy first. Patients who identified as female were more likely to receive any gender-affirming treatment than male-identifying or nonbinary patients. These findings characterize some of the many factors that impact the timing and type of care gender diverse patients receive. These data further our understanding of the pediatric gender diverse population and of their medical gender-affirming care needs.
ISSN:1936-1653
1936-1661
DOI:10.1080/19361653.2022.2139788